Federica Sallusto

A Shift in the Phenotype of Melan-A-Specific CTL Identifies Melanoma Patients with an Active Tumor-Specific Immune Response1

A. Harris, F. Sallusto, A. Lanzavecchia, 2000, The Journal of Immunology.